Ingen internetforbindelse — viser den gemte version af siden.

Merck KGaA ADR

USUSD
← Til screeneren

Merck KGaA ADR (MI:1MRKX) — Biotechnology: Pharmaceutical Preparations. Antal børser, hvor selskabets aktier handles: 6. På denne side — kurs og diagram, udbytte, største aktionærer og historik over antal aktier.

⚠ Forveksl dem ikke: der findes et andet firma med samme eller et meget lignende navn. Det er en separat registrering — tjek ticker, børs og registreringsnummer.
  • Merck KGaA — MRK · XETRA DE Registreringsnummer ukendt

Om virksomheden

Websted
merck.com
Sektor
Health Care · Biotechnology: Pharmaceutical Preparations
Hovedkontor
RAHWAY, Germany
Administrerende direktør
Dr. Kai Beckmann
Ansatte
62 136
Børsnoteret siden
22.11.2023 (MI:1MRKX)
Udestående aktier
2.47 mia. pr. 2026-07-31
Free float
644.35 mio.
Markedsværdi
67.93 mia. USD
Insidere
0%
Institutionelle investorer
0.02%
Branche (SIC)
Pharmaceutical Preparations
Juridisk form
XSNP
ISIN
US58933Y1055
LEI
4YV9Y5M8S0BRK1RP0397
Udbetalingsgrad
262%
FCF
16.1 mia. USD
52%
Gæld
53.9 mia. USD
2.9 år FCF
Udbyttestreak
56+ år
Indtjening, FCF og udbytte — for de 12 måneder frem til 30.06.2026 (virksomhedens seneste rapport).
Beskrivelse

Merck KGaA operates as a science and technology company in Europe, North America, Latin America, Middle East and Africa, and the Asia Pacific. The Life Science segment offers products, solutions, and services to academic, research and diagnostic labs, biotech, and pharmaceutical companies, as well as the industrial sector; reagents, consumables, devices, instruments, software, and services for research, production, and testing to lab water instruments, microbiology and biomonitoring products, test assays, analytical reagents, and flow cytometry kits and instruments. This segment also provides traditional and novel therapies, such as ration devices, chromatography resins, single-use systems, process chemicals, and excipients for bioprocessing; contract development, manufacturing and testing services, which supports customers from preclinical phases to commercialization. The Healthcare segment discovers, develops, manufactures, and markets prescription drugs and biopharmaceuticals to the therapeutic areas of oncology, rare diseases, neurology and immunology, fertility, cardiovascular, and metabolic and endocrinological disorders. The Electronics segment offers advanced dielectric and metallic materials; photoresist, anti-reflective coating, and material lithography products; clean and selective etch chemistries; materials for chemical-mechanical planarization; high-purity gases for semiconductor manufacturing; and develops and installs delivery equipment for handling of specialty chemicals and gases for semiconductor manufacturing; develops modulating, creating, engineering, and guiding light; and material solutions in liquid crystals, OLED materials, and photoresists. It has in-licensing agreement with Abbisko Therapeutics Co. Ltd., China on drug candidates for the treatment of tenosynovial giant cell tumor; and strategic partnership with Versant Ventures to advance treatments for rare genetic cardiomyopathies. The company was founded in 1668 and is headquartered in Darmstadt, Germany. Merck KGaA operates as a subsidiary of E. Merck KG.

Børser og tickere

BørsTickerValutaPrisType
US USA StocksMRK sekundærUSD142.79 +0.60%almindelige aktier
LSE London Stock Exchange0QAH IOBUSD148.65 -0.12%almindelige aktier
MI Borsa Italiana (Milan)1MRKX primærEUR128.52 +2.11%almindelige aktier
MX Mexican Stock ExchangeMRK sekundærMXN2 561 +0.91%almindelige aktier
VI Vienna Stock ExchangeMRK sekundærEUR129.76almindelige aktier
XETRA Xetra6MK sekundærEUR129.78 +0.09%almindelige aktier

Kurs over 3 måneder

stigningsdag faldsdag udbyttets ex-dato udbetalingsdatoHold musen over / tryk på en dag — åbnings-, luknings-, højeste og laveste kurs

Udbytte

De sidste 12 måneder, MI:1MRKX: 3.0202 EUR (4 udb.)

Merck KGaA ADR (1MRKX) udbetaler udbytte kvartalsvis. I løbet af de sidste 12 måneder blev der betalt 3.0202 EUR pr. Aktie (betalinger: 4). Det svarer til cirka 2.35% af den nuværende aktiekurs. Baseret på betalingshistorikken forventes næste ex-udbyttedato omkring 15.12.2026. Uafbrudt udbyttehistorik: 56 år.

Ex-datoUdbetalingBeløb%TypeTicker
2026-09-15—0.7551 EUR0.6/2.4 %kvartalsvisMI:1MRKX
2026-06-15—0.7551 EUR0.6/2.3 %kvartalsvisMI:1MRKX
2026-03-16—0.7551 EUR0.6/2.3 %kvartalsvisMI:1MRKX
2025-12-15—0.7551 EUR0.6/2.3 %kvartalsvisMI:1MRKX
2025-09-15—0.7195 EUR0.6/2.2 %kvartalsvisMI:1MRKX
2025-06-16—0.7195 EUR0.6/2.2 %kvartalsvisMI:1MRKX
2025-03-17—0.7195 EUR0.6/2.2 %kvartalsvisMI:1MRKX
2024-12-16—0.7195 EUR0.6/2.2 %kvartalsvisMI:1MRKX
2024-09-16—0.6840 EUR0.5/2.1 %kvartalsvisMI:1MRKX
2024-06-17—0.6840 EUR0.5/1.6 %kvartalsvisMI:1MRKX
2024-03-14—0.6840 EUR0.5/1.1 %kvartalsvisMI:1MRKX
2023-12-14—0.6840 EUR0.5/0.5 %kvartalsvisMI:1MRKX

Nyheder denne uge

Endnu ingen nyheder fra virksomhedens websted.

annonce

Største ejere

EjerAndelAktierRapportdato
BlackRock9.2%227 mio.2026-06-30
Vanguard Capital Managem…6.54%161.32 mio.2026-06-30
State Street Corporation4.88%120.41 mio.2026-06-30
Wellington Management Gr…3.5%86.25 mio.2026-06-30
VANGUARD INDEX FUNDS-Van…3.18%78.41 mio.2026-06-30
Vanguard Portfolio Manag…2.75%67.74 mio.2026-06-30
VANGUARD INDEX FUNDS-Van…2.59%64 mio.2026-06-30
Geode Capital Management…2.46%60.74 mio.2026-06-30
Charles Schwab Investmen…2.2%54.37 mio.2026-06-30
Morgan Stanley1.97%48.64 mio.2026-06-30
FMR, LLC1.84%45.44 mio.2026-06-30
JPMORGAN CHASE & CO1.78%43.89 mio.2026-06-30
iShares Trust-iShares Co…1.33%32.89 mio.2026-08-31
Fidelity Concord Street…1.29%31.94 mio.2026-07-31
SCHWAB STRATEGIC TRUST-S…1.25%30.86 mio.2026-05-31
SPDR S&P 500 ETF TRUST-S…1.22%30.22 mio.2026-08-31
VANGUARD INDEX FUNDS-Van…0.95%23.51 mio.2026-06-30
SELECT SECTOR SPDR TRT-S…0.72%17.75 mio.2026-08-31
VANGUARD SPECIALIZED FUN…0.65%15.95 mio.2026-07-31
VANGUARD SPECIALIZED FUN…0.57%13.97 mio.2026-07-31
DAVIS ROBERT M (Chief Ex…≈0.02%450 3512026-04-29
CHATTOPADHYAY SANAT (Off…≈0.01%200 6752026-04-29
DELUCA RICHARD ROBERT JR…≈0%110 1672026-08-12
LI DEAN Y (Officer)≈0%94 4312026-04-29
LITCHFIELD CAROLINE (Chi…≈0%92 3002026-04-29
ZACHARY JENNIFER L (Gene…≈0%45 5092026-08-12
GUINDO CHIRFI (Officer)≈0%36 6132026-08-13
WILLIAMS DAVID MICHAEL (…≈0%31 7162026-08-05
ROMANELLI JOSEPH EDWARD…≈0%28 7392026-01-26
OOSTHUIZEN JOHANNES JACO…≈0%21 8952026-04-29
Trust for Professional M…0%24 8032026-05-31
Rhumbline Advisers0%10 9192026-06-30
SP Funds Trust-SP Funds…0%6 5422026-07-31
Atlas Capital Advisors I…0%2 4672026-06-30
Gamma Investing LLC0%2 3022026-06-30
Salomon & Ludwin, LLC0%3562026-06-30
PNC Financial Services G…0%22026-06-30
The Vanguard Group———